Skip to content

Organ Donation Evidence

SHE-ROCKS – Sex and Health; Evaluating diagnosis, Risk factOrs and Complications in chronic Kidney disease

SHE-ROCKS is a collaborative project between CODE at the University of Sydney and researchers at the University of Glasgow, and is supported by a University of Sydney- University of Glasgow Partnership Collaboration Award 2022. We know females have poorer outcomes than males in kidney failure… Read More »SHE-ROCKS – Sex and Health; Evaluating diagnosis, Risk factOrs and Complications in chronic Kidney disease

ASSET NSW- AcceSS and Equity in Kidney Disease and Transplantation: impact of severe and persistent mental illness, New South Wales

The Mental Health Living Longer (MHLL) programme established a population-wide data linkage to support research translation and service reform for mental health in New South Wales (NSW), Australia (learn more about it here: Mental Health Living Longer (MHLL) protocol ). In partnership with the MHLL… Read More »ASSET NSW- AcceSS and Equity in Kidney Disease and Transplantation: impact of severe and persistent mental illness, New South Wales

I-MAGICK – Improving health MAnaGement In people with advanced Chronic Kidney disease

The I-MAGICK study uses data linkage to evaluate the health service delivery for people with advanced chronic kidney disease (CKD) affected by multimorbidity, including cardiovascular disease and mental health conditions. We are developing evidence to improve equitable delivery of health care and services, including cardiovascular… Read More »I-MAGICK – Improving health MAnaGement In people with advanced Chronic Kidney disease

ReSKiTE – Relative Survival from cancer in Kidney Transplant recipients and people with End-stage kidney disease in Australia and New Zealand

Relative survival provides a more reliable measure of excess mortality for people diagnosed with cancer. In the general population with cancer, the relative survival has increased to 68% in 2009-13 but estimates for the kidney failure and kidney transplant population with cancer are unknown. ReSKiTE… Read More »ReSKiTE – Relative Survival from cancer in Kidney Transplant recipients and people with End-stage kidney disease in Australia and New Zealand

Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000–2015

After organ transplantation, infections, including common communicable infections such as influenza, frequently cause disease, although the actual amount of infection and disease is unclear. We aimed to measure the burden of notifiable infectious diseases in an Australian cohort of transplant recipients compared with the general… Read More »Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000–2015

Potential organ donors with primary brain tumours: missed opportunities for donation and transplantation identified in Australian cohort study 2010–2015

Potential organ donors with primary brain tumours (PBT) frequently donate, however some may be declined due to uncertainty about tumour classification or transmission risk to transplant recipients. We sought to describe transmission risk and donation outcome of potential donors with PBT, including identifying missed opportunities… Read More »Potential organ donors with primary brain tumours: missed opportunities for donation and transplantation identified in Australian cohort study 2010–2015

29th International Congress of The Transplantation Society (TTS 2022), Buenos Aires, Argentina

Dr Nicole De La Mata presenting: poster Patient experience of the kidney transplant waitlist: An Australian cohort study Dr Brenda Rosales presenting: mini oral Natural history of CXCR5+ t follicular-like helper (TFH) cells in kidney transplant recipients with rejection James Hedley presenting mini oral Cost-effectiveness… Read More »29th International Congress of The Transplantation Society (TTS 2022), Buenos Aires, Argentina